Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease

por McCarthy, Gizelle M., Blasio, Angelo, Donovan, Olivia G., Schaller, Lena B., Bock-Hughes, Althea, Magraner, Jose M., Suh, Jung Hee, Tattersfield, Calum F., Stillman, Isaac E., Shah, Shrijal S., Zsengeller, Zsuzsanna K., Subramanian, Balajikarthick, Friedman, David J., Pollak, Martin R.
Publicado 2021